Bright Green signs letter of intent with Alterola Biotech on shares purchase
Bright Green signs letter of intent with Alterola Biotech on shares purchase
4.38MUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
02071K105
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.00
Dividend Share
-
Dividend Yield
-
Earnings Share
0
Wall Street Target Price
-
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-
Profit Margin
0.00%
Return On Assets TTM
-19.39%
Return On Equity TTM
-52.95%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
0
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
0.522
Enterprise Value Revenue
0
Enterprise Value EBITDA
-3
147.55
1.93%29.06
0.73%21.05
0.26%13.08
0.23%20.29
0.00%24.25
-7.34%4.21
-3.66%139.50
-2.51%163.50
-0.54%42.07
-0.36%